相关实验视频

Updated: May 1, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

探索在糖尿病脏病中阿迪波金介导的氏醇基因和T细胞之间的相互作用:一种基于孟德尔随机化的因果推断

Xiaojuan Wang^1,2, Mohamad Hafizi Abu Bakar³, Mohd Asyraf Kassim²

¹Department of Pharmacy, Taishan Vocational College of Nursing, Tai'an, Shandong, 271099, China.

Diabetology & metabolic syndrome

|March 19, 2025

概括

塞拉斯托尔向FGF9,MAGI2和THBS2等关键基因,通过影响adipokine-immune交叉和脂质代谢来调节糖尿病病 (DN). 这为新的DN生物标志物和疗法提供了潜力.

科学领域:

内分泌学在内分泌学.
腎臟病學 (nephrology) 是一種醫學.
免疫学免疫学免疫学

背景情况:

糖尿病病 (DN) 涉及失调的阿迪波金,影响炎症和新陈代谢.
连接阿迪波金,免疫细胞和DNA代谢变化的确切机制尚未完全理解.
塞拉斯在减轻损伤方面显示出潜力,但其在DN的阿迪波金-免疫相互作用中的特定作用需要澄清.

研究的目的:

阐明糖尿病病 (DN) 中阿迪波金介导的基因之间的相互作用.
为了研究切拉斯特如何调节DNA中的这些相互作用.
确定DN.的潜在治疗点和生物标志物.

主要方法:

从DN患者数据集 (GSE30122,GSE30528) 中分析基因表达特征.
利用基因组变异分析 (GSVA) 检测脂质代谢途径.
采用孟德尔随机化 (MR) 和皮尔森相关性来评估基因-阿迪波金关联和免疫细胞透.

主要成果:

在DNA中确定了70个差异表达基因 (DEGs).
发现改变了脂肪细胞分化途径,发现了阿迪波内克丁,莱普和抵抗素与DN的显著关联.
突出了FGF9,MAGI2和THBS2作为与DN风险和T细胞透相关的关键基因,其中确定了22个素向基因.

结论:

塞拉斯托尔通过阿迪波金-免疫交叉影响DN进展.
FGF9,MAGI2和THBS2被确定为DNA中的关键调节基因.
这些发现表明了DN生物标志物发现和治疗开发的新途径.

关键词:

艾迪波基因 (Adipokine) 是一种可怕的药物.塞拉斯特罗尔 (celastrol) 是一种糖尿病脏病糖尿病脏病免疫细胞是免疫细胞.免疫系统的透.门德尔的随机化

更多相关视频

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

相关概念视频

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...